Document Detail


Effects of SMYD3 over-expression on cell cycle acceleration and cell proliferation in MDA-MB-231 human breast cancer cells.
MedLine Citation:
PMID:  20957523     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
SET and MYND domain-containing protein 3 (SMYD3) is a histone methyltransferase that plays an important role in transcriptional regulation in human carcinogenesis. It can specifically methylate histone H3 at lysine 4 and activate the transcription of a set of downstream genes, including several oncogenes (e.g., N-myc, CrkL, Wnt10b, RIZ and hTERT) and genes involved in the control of cell cycle (e.g., CyclinG1 and CDK2) and signal transduction (e.g., STAT1, MAP3K11 and PIK3CB). To determine the effects of SMYD3 over-expression on cell proliferation, we transfected SMYD3 into MDA-MB-231 cells and found that these cells showed several transformed phenotypes as demonstrated by colony growth in soft agar. Besides, we show here that down-regulation of SMYD3 could induce G1-phase cell cycle arrest, indicating the potent induction of apoptosis by SMYD3 knockdown. These results suggest the regulatory mechanisms of SMYD3 on the acceleration of cell cycle and facilitate the development of strategies that may inhibit the progression of cell cycle in breast cancer cells.
Authors:
Tian-Nian Ren; Jing-Song Wang; Yun-Mian He; Chang-Liang Xu; Shu-Zhen Wang; Tao Xi
Related Documents :
15199223 - Cd40: a growing cytoplasmic tale.
12509523 - Altered cell cycle distribution, hyperplasia, and inhibited differentiation in arabidop...
2298693 - Pyrogallol-to-phloroglucinol conversion and other hydroxyl-transfer reactions catalyzed...
Publication Detail:
Type:  Journal Article     Date:  2010-10-19
Journal Detail:
Title:  Medical oncology (Northwood, London, England)     Volume:  28 Suppl 1     ISSN:  1559-131X     ISO Abbreviation:  Med. Oncol.     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9435512     Medline TA:  Med Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  91-8     Citation Subset:  IM    
Affiliation:
School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, People's Republic of China, rentiannian@163.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A Proteomic Investigation of B Lymphocytes in an Autistic Family: A Pilot Study of Exposure to Natur...
Next Document:  Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular ca...